In addition, the PainChek® Infant app, which identifies and detects six facial action units indicative of post-procedural pain in infants aged one month to 12 months, has received regulatory clearance in New Zealand, the UK, Australia, Europe, Singapore, and Canada, with FDA review in the US currently in progress
Interesting. I did not know that officially, they have already obtained regulatory clearance in those jurisdictions for the Infant app (one month to 12 months old) for post-procedural pain. I don't remember seeing an announcement for such. I actually thought the trial was still ongoing. Especially surprising to see it approved in Singapore as well.
Looking good and progressing nicely.
Media Thread, page-1215
-
- There are more pages in this discussion • 498 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 497311 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 254838 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PCK (ASX) Chart |